Skip to main content
. Author manuscript; available in PMC: 2011 Feb 18.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2008 Apr 24;72(2):474–484. doi: 10.1016/j.ijrobp.2008.01.039

Fig. 1.

Fig. 1

(Top left) Overall survival (OS), locoregional control (LRC), and distant metastasis–free survival (DMFS) in all patients in the series (n = 256). (Top right) OS in patients able to complete combined-modality therapy as intended (group 1, n = 192) vs. OS in patients who did not complete therapy as intended (group 2, n = 64). (Bottom left) LRC as a function of group. (Bottom right) DMFS as a function of group.